Pharvaris aims to

set people living with HAE free

We aim to provide

freedom from HAE symptoms

We aim to provide

freedom from attacks

We aim to provide

freedom from injections

Pioneering Science for Patient Choice

Advancing new oral alternatives for all people living with hereditary angioedema (HAE)

View our Science

Pharvaris aims to develop novel, oral alternatives that improve the standard of care for people living with HAE.

View our Pipeline


Oral prophylactic treatment study


Extension study of oral on-demand treatment

Pharvaris is a leader in bradykinin-mediated diseases, aiming to deliver effective, safe and easy to administer therapies.

View our Science

Pharvaris is committed to improving the treatment of HAE and the quality of life for people living with HAE.

HAE Community

Our legacy in HAE, our scientific expertise, and our values drive our passion as we aspire to provide choice to people living with HAE.

About Us